Reviews

Financial toxicity in cancer care

Author and Disclosure Information

 

The cost of cancer care is increasing, with important implications for the delivery of high-quality, patient-centered care. In the clinical setting, patients and physicians express a desire to discuss out-of-pocket costs. Nevertheless, both groups feel inadequately prepared to participate in these discussions, and perhaps not surprisingly, the integration of these discussions into clinical practice seems to be the exception rather than the rule.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Radiotherapy for prostate cancer linked to higher risk of secondary malignancies
MDedge Hematology and Oncology
Children’s cancer survival steadily increasing
MDedge Hematology and Oncology
New drug comparable to voriconazole for aspergillosis
MDedge Hematology and Oncology
Children who have stem cell transplants need skin exams, sun protection
MDedge Hematology and Oncology
New prediction tool forecasts long-term ICU outcomes for very elderly
MDedge Hematology and Oncology
When toenail onychomycosis can turn deadly
MDedge Hematology and Oncology
New CDC opioid guideline targets overprescribing for chronic pain
MDedge Hematology and Oncology
ABMS approves new addiction medicine subspecialty
MDedge Hematology and Oncology
CT of chest, extremity effective for sarcoma follow-up
MDedge Hematology and Oncology
Opioid risk assessment in palliative medicine
MDedge Hematology and Oncology